baber/WOPTO huggingface dataset:
Patent NZ-608064-A (NZ)
Title: Treatment of biomass
Inventor: GAPES DANIEL JAMES
IPC: C12P7/64
Filed: 2012-02-28
Abstract: Disclosed is a process for the treatment of biomass comprising (1) subjecting biomass to anaerobic microbial digestion for about 0.5 to about 20 days under conditions so as to convert at least a portion of the organic biomass to volatile fatty acids and/or solvents while leaving at least some of the organic biomass in the form of biosolids or unconverted organic material and minimising methanogenesis to create a mixture of biosolids, unconverted organic biomass and volatile fatty acids and/or solvents, and (2) subjecting the mixture to wet oxidation thereby reducing biosolid volume and producing a resulting mixture under conditions that do not result in the mass destruction of the volatile fatty acids and/or solvents. Further disclosed is a process for the treatment of biomass comprising (1) subjecting biomass to anaerobic microbial digestion for about 0.5 to about 20 days by contacting biomass with one or more microorganisms under conditions that promote acidogenesis while retarding methanogenesis to produce a mixture comprising (a) volatile fatty acids and/or solvents such as short chain (C1 to C7) fatty acids, short chain (C1 to C7) alcohols, short chain (C1 to C7) ketones or any mixture of any two or more thereof, and (b) undigested biomass, and (2) subjecting at least a portion of the mixture to wet oxidation under conditions to reduce the volume of the undigested biomass while maintaining or increasing the concentration of the volatile fatty acids and/or solvents that are present.
Patent NZ-609066-A (NZ)
Title: Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methods
Inventor: GRAUS PORTA DIANA
IPC: G01N33/84
Filed: 2009-04-28
Abstract: The disclosure relates to use of inorganic phosphorus (P) or the product of phosphorus and total calcium (P x tCa) as a biomarker for monitoring the inhibition of kinase activity of fibroblast growth factor receptor (FGFR) and for determining therapeutic efficacy and/or one or more secondary effects of FGFR inhibitor, wherein the secondary effect is ectopic mineralization, and wherein the FGFR inhibitor is selected from compound A (3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[ 4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-25 yl}-1-methyl urea), TKI258, or a pharmaceutically acceptable salt thereof.
Patent NZ-610584-A (NZ)
Title: Signal amplification
Inventor: TODD ALISON VELYIAN
IPC: C12Q1/68
Filed: 2011-11-21
Abstract: Disclosed is a composition comprising a first Enzyme Amplifier Substrate oligonucleotide (EAS 1) and a second Enzyme Amplifier Substrate oligonucleotide (EAS2), wherein: a portion of the EAS 1 is complementary to a portion of the EAS2, the EAS 1 and EAS2 form a first Complete Enzyme Signal Amplifier (CESA) complex comprising a recognition and a cleavage sequence for a first nuclease only on assembly with a first Driver Fragment oligonucleotide (DF), a portion of the first DF is complementary to a portion of the EAS 1, and binding of the first DF to said EAS 1 completes a partial nuclease recognition or cleavage sequence.
Patent NZ-614810-A (NZ)
Title: Online content collection
Inventor: JARRED HOLMAN
IPC: G06Q30/02
Filed: 2013-08-28
Abstract: Disclosed is an online content collection system (120). The system (120) includes a scanning server (123) to scan web sites to retrieve a potential creative (111a-n) uniform resource locator (URL). The scanning and retrieving involves parsing web pages (110x) for the web sites, identifying a potential creative (111a-n) URL from the parsed web pages (110x) that matches a predetermined criterion for retrieving potential creative (111a-n) URLs, and retrieving the potential creative (111a-n) URL that matches the predetermined criterion. The system (120) also includes data storage that stores creative (111a-n) URLs and an online content collection server (123) that analyses the retrieved potential creative (111a-n) URL. The analysing includes determining whether the retrieved potential creative (111a-n) URL has been seen before by comparing the retrieved potential creative (111a-n) URL against the creative (111a-n) URLs stored in the data storage. Query parameters are then removed before determining whether the retrieved potential creative (111a-n) URL has been seen before and a creative (111a-n) is downloaded that the retrieved potential creative (111a-n) URL points to if the retrieved potential creative (111a-n) URL has not been seen before. A determination is then made as to whether the retrieved potential creative (111a-n) URL points to a creative (111a-n) if the retrieved potential creative (111a-n) URL has been seen before, and to whether the retrieved potential creative (111a-n) URL with query parameters has been seen before if the retrieved potential creative (111a-n) URL does not point to a creative (111a-n). Finally, a determination is made as to whether the online content collection server (123) recognizes a click thru URL associated with the creative (111a-n) if the retrieved potential creative (111a-n) URL points to a creative (111a-n) and whether web page content associated with the creative (111a-n) includes a click thru URL if the online content collection server (123) does not recognize the click thru URL associated with the creative (111a-n). If the web page content associated with the creative (111a-n) includes a click thru URL, the click thru URL is downloaded in a web browser environment and checked whether the click thru URL is a redirected URL or not.
Patent NZ-617624-A (NZ)
Title: 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
Inventor: AISSAOUI HAMED
IPC: C07D471/04
Filed: 2012-04-13
Abstract: The disclosure relates to 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives of the formula (I), wherein R1, R2, R3 and R4 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D2 receptor modulators. The disclosure also relates to pharmaceutical compositions containing these compounds and their use in the treatment of chronic and acute allergic/immune diseases/disorders, including asthma, food allergy, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease and rheumatoid arthritis. Example compounds include: 2-(7-((6-fluorobenzo[d]thiazol-2-yl)(methyl)amino)-2-(trifluoromethoxy)-6,7,8,9-tetrahydropyrido[1 ,2-a]indol-10-yl)acetic acid; 2-(7-((5-fluorobenzo[d]oxazol-2-yl)(methyl)amino)-3-(trifluoromethyl)-6, 7,8,9-tetrahydropyrido[1 ,2-a]indol-10-yl)acetic acid; 2-(7-((5-fluorobenzo[d]oxazol-2-yl)(methyl)amino)-2-(trifluoromethoxy)-6, 7,8,9-tetrahydropyrido[1 ,2-a]indol-10-yl)acetic acid; 2-(3-chloro-7-((5-fluoropyrimidin-2-yl)(methyl)amino)-6,7,8,9-tetrahydropyrido[1 ,2-a]indol-10-yl)acetic acid; 2-(2-fluoro-7-((5-fluorobenzo[d]oxazol-2-yl)(methyl)amino)-6,7,8,9-tetrahydropyrido[1 ,2-a]indol-10-yl)acetic acid; 2-(3-fluoro-7-((5-fluoropyrimidin-2-yl)(methyl)amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl)acetic acid.
Patent NZ-628907-A (NZ)
Title: Carton with tray
Inventor: KOHLER KARL A
IPC: B31B50/86
Filed: 2013-03-04
Abstract: A carton for holding two or more layers of products with a seam or strip that can be cut, torn or ripped to open the carton and a tray or insert to divide the stacks of products. The carton allows for quick separation of the two layers of product by tearing the tear strips (74) along the line of weakness and removing the tray (see Fig. 3), to make two single stacks of product. The carton includes a plurality of panels, at least one having an opening feature or tear strip (74, 78) and a tray, rack, pallet or platter with a handle (126) accessible from outside the carton. The tray separates two or more layers of product (C).
Patent NZ-709323-A (NZ)
Title: Plastic film
Inventor: BOLOM WOLFGANG
IPC: B32B27/32
Filed: 2013-12-16
Abstract: The invention relates to a plastic film (1) for wrapping silage material (2), comprising a single-ply or multi-ply outer layer (3), a single-ply or multi-ply inner layer (4), and an intermediate layer (5) arranged between the outer layer (3) and the inner layer (4). The outer layer (3), the inner layer (4), and the intermediate layer (5) are designed to be gas-tight and at least partly translucent, preferably completely translucent, in the visible spectrum.
Patent NZ-730979-A (NZ)
Title: Systems and methods for forming and maintaining a high performance frc
Inventor: BINDERBAUER MICHL
IPC: H05H1/14
Filed: 2015-10-30
Abstract: A high performance field reversed configuration (FRC) system includes a central confinement vessel, two diametrically opposed reversed-field-theta-pinch formation sections coupled to the vessel, and two divertor chambers coupled to the formation sections. A magnetic system includes quasi-dc coils axially positioned along the FRC system components, quasi-dc mirror coils between the confinement chamber and the formation sections, and mirror plugs between the formation sections and the divertors. The formation sections include modular pulsed power formation systems enabling static and dynamic formation and acceleration of the FRCs. The FRC system further includes neutral atom beam injectors, pellet or CT injectors, gettering systems, axial plasma guns and flux surface biasing electrodes. The beam injectors are preferably angled toward the midplane of the chamber. In operation, FRC plasma parameters including plasma thermal energy, total particle numbers, radius and trapped magnetic flux, are sustainable at or about a constant value without decay during neutral beam injection.
Patent NZ-731111-A (NZ)
Title: Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
Inventor: FISCHETTI VINCENT
IPC: A61K38/46
Filed: 2012-04-20
Abstract: Discloses is a chimeric protein comprising the catalytic domain or binding domain of the isolated lysin polypeptide comprising the amino acid sequence of SEQ ID NO:3 or variants thereof having at least 80% identity to the polypeptide of SEQ ID NO:3 and effective to kill gram-positive bacteria, said catalytic domain or binding domain operably linked to a heterologous protein or polypeptide or covalently attached to an entity which provides additional function or enhances the use or application of the lysin polypeptide. Also disclosed is pharmaceutical compositions, nucleic acids and uses of the chimeric protein.
Patent NZ-734909-A (NZ)
Title: System and method for object tracking anti-jitter filtering
Inventor: EVANSEN EDWARD
IPC: G06T19/20
Filed: 2013-11-12
Abstract: Problems in object tracking can occur where: when objects are stationary, noise becomes more visible; when multiple objects are closely crowded, signals are blocked and missed; when objects are leaning over, it results in less accurate collection of raw location points. Object tracking anti-jitter filtering systems and methods are disclosed. An object tracking anti-jitter filtering method receives a plurality of raw location points for a tracking tag attached to a tracked object is received. The raw location points are averaged corresponding to an averaging window to periodically generate an averaged location point. Physical movement of the tracked object is determined based upon three most recently determined average location points corresponding to the object. A most recent of the three average location points is adjusted such that the determined physical movement of the tracked object does not exceed predefined physical limits of the tracked object. Methods, apparatus, and computer program products for monitoring a participant are also disclosed. At least one tag is correlated to the participant. Blink data transmitted by the at least one tag is received. Tag location data is determined based on the blink data. A sensor is correlated to the participant. Sensor derived data is received. The participant location data is determined based on the tag location data, the sensor derived data, and participant dynamics/kinetics models.
Patent NZ-740314-A (NZ)
Title: Systems and methods for improved focus tracking using blocking structures
Inventor: DAVID HARGIS
IPC: G03B3/00
Filed: 2018-02-27
Abstract: Many pre-existing scanning systems use a multi-beam focus track system to determine focus distances for a given sample. Improving focus accuracy and the speed with which the system can determine the focus setting can be important in that it can allow the system to achieve better results. Systems and methods disclosed herein for improving accuracy of focus tracking in optical systems include an optical blocking structure that may include a frame defining an aperture, first and second elongate structural members each comprising first and second ends such that the first and second elongate structural members may be connected at their first ends to opposite sides of the aperture, and further such that the first and second elongate structural members may extend from the frame parallel to and in the same direction as one another; and an optically opaque blocking member positioned to extend between the respective second ends of the first and second blocking members.
Patent NZ-740910-A (NZ)
Title: Going on location feasibility taking into account off-shore location ocean conditons
Inventor: MELKOWITS MASON COREY
IPC: G06F9/54
Filed: 2016-08-25
Abstract: Techniques and devices to assist an offshore unit (2) in going on location and coming off location. A device (20) may include an interface (34) configured to receive a signal indicative of motions of an offshore unit (2). The device (20) may also include a memory (28) configured to store a set of values corresponding to acceptable motions of the offshore unit (2), as well as a processor (26) configured to determine if a measured motion of the offshore unit (2) exceeds at least one value of the set of values and generate an indication that going on location by the offshore unit (2) can be undertaken when the processor (26) determines that the measured motion of the offshore unit (2) is less than or equal to the at least one value.
Patent NZ-746607-A (NZ)
Title: Substituted reverse pyrimidine bmi-1 inhibitors
Inventor: DU WU
IPC: C07D471/04
Filed: 2013-11-21
Abstract: Amine substituted reverse pyrimidine compounds and forms thereof that inhibit the function and reduce the level of B-cell specific Moloney murine leukemia virus integration site 1 (Bmi-1) protein and methods for their use to inhibit Bmi-1 function and reduce the level of Bmi-1 to treat a cancer mediated by Bmi-1 are described herein. Compounds of Formula (I) are described, wherein X, R1, R2, R3 and R4 are as defined herein. Compounds wherein R1 is 1H-imidazo[4,5-b]pyridinyl, substituted on a carbon atom ring member with one, two, three or four R5 substituents (wherein R5 is as defined herein), or on a nitrogen atom ring member with an oxygen atom substituent to form an N-oxide are claimed.
Patent NZ-746922-A (NZ)
Title: Enablement of device power-on with proper assembly
Inventor: PENNY JUNIUS
IPC: G01R35/00
Filed: 2017-04-28
Abstract: An electronic device is configured with sub-assemblies including a main logic board, flexible printed circuit, and dual battery packs that are assembled together with electrical connectors to enable power from the battery packs to flow over a power bus that is distributed along the flexible printed circuit and main logic board. A protection circuit module (PCM) in each battery pack is configured to determine a state of each of the connections among the sub-assemblies (i.e., whether or not properly assembled to provide electrical continuity through the connector) so that power from the battery packs is switched on to the power bus only when electrical continuity is verified at each of the connectors. In the event that any connection is faulty, for example due to a misalignment of a connector during assembly that prevents electrical continuity to be established through a connector, neither PCM will switch power on to the power bus.
Patent NZ-757538-A (NZ)
Title: Reducing beta-catenin expression to potentiate immunotherapy
Inventor: GANESH SHANTHI
IPC: A61K39/395
Filed: 2018-03-28
Abstract: Provided herein are methods and compositions for treating cancer, including cancer that is not responsive to immunotherapy. In one aspect, the methods of treatment comprise administering to the subject a therapeutically effective amount of a β-catenin inhibitor and a therapeutically effective amount of an immunotherapeutic agent. Another aspect is directed to pharmaceutical compositions comprising a β-catenin inhibitor for use in treating cancer, wherein the composition is administered in combination with an immunotherapeutic agent. Yet another aspect is directed to a method of potentiating the therapeutic effect of immunotherapy against a cancer using a β-catenin inhibitor, such as a β-catenin nucleic acid inhibitor molecule.
Patent NZ-759007-A (NZ)
Title: Helmet
Inventor: HALLDIN PETER
IPC: A42B3/06
Filed: 2018-05-18
Abstract: A helmet (1) comprising an energy absorbing layer (3), a relatively hard layer (2) that is harder than the energy absorbing layer (3) and is formed outward of the energy absorbing layer (3) and a plurality of outer plates (20) mounted on the outer surface of the relatively hard layer (2); wherein the outer plates (20) are mounted on the relatively hard layer (2) such that, under an impact to an outer plate (20), the outer plate (20) can slide across the relatively hard layer (2) and move relative to other outer plates (20); and a low friction interface is provided between the outer surface of the relatively hard layer (2) and at least a part of the surface of the outer plates (20) that is in contact with the outer surface of the relatively hard layer (2) under an impact to an outer plate (20). Figure 6 A helmet (1) comprising an energy absorbing layer (3), a relatively hard layer (2) that is harder than the energy absorbing layer (3) and is formed outward of the energy absorbing layer (3) and a plurality of outer plates (20) mounted on the outer surface of the relatively hard layer (2); wherein the outer plates (20) are mounted on the relatively hard layer (2) such that, under an impact to an outer plate (20), the outer plate (20) can slide across the relatively hard layer (2) and move relative to other outer plates (20); and a low friction interface is provided between the outer surface of the relatively hard layer (2) and at least a part of the surface of the outer plates (20) that is in contact with the outer surface of the relatively hard layer (2) under an impact to an outer plate (20).
Patent NZ-760903-A (NZ)
Title: Disease resistance loci in onion
Inventor: RICK JONES
IPC: A01H1/04
Filed: 2014-09-09
Abstract: Disclosed is a method of detecting in at least one onion plant a genotype associated with bulb colour, the method comprising the step of: detecting in at least one onion plant an allele of at least one polymorphic nucleic acid that is associated with bulb colour, wherein the polymorphic nucleic acid is in or genetically linked to an onion genomic region defined by the loci NQ0257378 (SEQ ID NO:64) and NQ0345734 (SEQ ID NO:74) on linkage group 6 (LG6), conferring a red pigment bulb colour. Further disclosed are methods of producing a plant or introgression methods with the phenotype as defined.
Patent NZ-768525-A (NZ)
Title: In-line sensor validation system
Inventor: BRENNAN JAMES
IPC: A23N12/02
Filed: 2015-10-05
Abstract: Disclosed is a food wash reference fluid delivery apparatus comprising a mobile frame and a reference fluid reservoir positioned on and configured to be removable from the mobile frame. The reference fluid reservoir is configured to contain a reference fluid with a predetermined concentration of an analyte. The food wash reference fluid delivery apparatus also comprises a coupler configured to fluidly couple with a sensor for a food wash system and a delivery assembly positioned on the mobile frame. The delivery assembly comprises a sensor fluid line configured to provide the reference fluid to the coupler, a pump configured to pump the reference fluid from the reference fluid reservoir to the sensor fluid line past the sensor, and a valve configured to control a fluid volumetric flow rate of the reference fluid through the sensor fluid line.
Patent NZ-778486-A (NZ)
Title: Proximate robot object detection and avoidance
Inventor: JOHNSON MICHAEL CHARLES
IPC: G05D1/02
Filed: 2020-01-31
Abstract: Systems and methods for proximate robot object detection and avoidance are provided herein which include a receiver in electronic communication with an autonomous robot and configured to receive a broadcast message from a beacon, a processor, and a memory, the memory storing instructions that, when executed by the processor, cause the autonomous robot to detect, based on the received broadcast message, a proximity of the beacon to the autonomous robot, determine, from the received broadcast message, a beacon status, the beacon status indicating whether the beacon is stationary, approaching the autonomous robot, or withdrawing from the autonomous robot, identify, according to the detected proximity and the determined beacon status, a corresponding proximity operation, and control the autonomous robot to stop an ordinary operation and operate according to the identified proximity operation.
Patent PT-100723-A (PT)
Inventor: CONSTANTINIDES PANAYIOTIS PERI
IPC: C09K23/44
Filed: 1992-07-24
Abstract: Pharmaceutically acceptable, stable, self-emulsifying (w/o) microemulsions comprising (i) a lipophilic phase comprising a long-chain fatty acid triglyceride and a low HLB surfactant, (ii) an aqueous-based hydrophilic phase containing a water-soluble therapeutic agent, and (iii) a high HLB surfactant have improved drug delivery characteristics.
Patent PT-102138-A (PT)
Title: System for preparing/treating cork bark by baking and continuous purification of the water
Inventor: GIL LUIS MANUEL DA COSTA CABRA
IPC: B27K7/00
Filed: 1998-03-24
Abstract: The present invention relates to a system for the preparation and/or treatment of cork bark for subsequent processing, specifically for the manufacture of stoppers, which makes it possible to bake the cork continuously at the same time as the baking water is purified continuously or semi-continuously. The system consists of a rotary structure 1 forming compartments 6, 6' or to which independent compartments are linked, for positioning of the cork-bark planks 10, said rotary structure 1 being fully or practically fully immersed in a tank of water that is thermally insulated and covered except at the location of a small upper opening. The tank has a water exit via which the baking water is forced to exit and subsequently to pass into a purification system that uses a variety of alternative processes, the water returning purified to the tank. The rotary structure 1 is caused to rotate via a drive device, that movement being transmitted by any suitable means, for example toothed wheels or casters, and the water is circulated between the tank and the purification system by means of a common pump device. This results in an integrated process that can be operated by a single person, in which continuous baking is carried out always with relatively pure water, and whose continuous or semi-continuous movement of the non-compacted planks in various positions inside the tank allows more homogeneous and more rapid baking operations, with a great saving in energy and minimum water consumption, together with less probability of future problems with the treated cork bark. <IMAGE>